ANDE vs REGN · P/E 12, rev $11.26B vs P/E 14, rev $14.34B
The Andersons Inc (ANDE) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
The Andersons Inc (ANDE) is a food distribution company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ANDE revenue for 2024-12-31 was $11.26B. Net income was $170.7M. Revenue was down 23.7% from 2023-12-31 to 2024-12-31. ANDE currently screens at market cap $1.31B and trailing P/E 12.1.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ANDE currently screens at market cap $1.31B and trailing P/E 12.1. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ANDE and REGN stock pages for the full models.
Not investment advice.